Fisher & Paykel Healthcare Corporation Ltd (FSPKF)

Fisher & Paykel Healthcare Ltd is a common stock listing on OTC Markets for a healthcare equipment company based in Auckland, New Zealand. Through its subsidiaries, the company develops, manufactures, markets, and sells medical device products and systems used in respiratory care and surgery, as well as in the treatment of obstructive sleep apnea in home and hospital settings. Its portfolio includes adult respiratory products such as the Airvo system, Optiflow nasal high flow therapy, and invasive and noninvasive ventilation solutions. The company also supplies infant respiratory products, along with hospital equipment and homecare products that include masks, CPAP devices, humidifiers, software and data management tools, and related accessories. Founded in 1934, Fisher & Paykel Healthcare serves customers across North America, Europe, the Asia Pacific, and other international markets.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-FSPK.F
$19.15
-25.7% Downside
Overvalued
Not available
Not available
Great
0.0%
December 1, 2026
55.2x
12.2x
11.2x
14.842 B
14.669 B
0.6%
99.7%
11.0
47.8%
104.7%
Valuation • Fair Value

Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) Fair Value by Valuation Model

Review the available estimates for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$19.15

Estimated downside of 25.7% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$19.03

Discounted cash flow valuation reference.

Ben Graham Formula Value

$4.50

Classic Ben Graham valuation formula reference.

Comps Fair Value

$19.27

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 5 available valuation references for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.327 B

Current operating scale indicator.

Revenue Forecast

1.469 B

Forward revenue estimate.

EBITDA

436.4 M

Current operating profitability reference.

EBITDA Forecast

522 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

9

Relatively strong quality score.

Beneish M-Score

-2.70

No elevated caution signal from this screen.

Altman Z-Score

11.0

Relatively strong balance-sheet zone.

FCF / Net Income

104.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

December 1, 2026

Days to Earnings

74

Dividend Yield

0.0%

No current dividend yield is indicated.

Payout Ratio

47.8%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) Stock FAQ

Data-supported answers about Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$19.15
Estimated downside 25.7%
Valuation Rating
Overvalued
Estimated downside of 25.7%
Financial Health
Great
Current financial-health read

The current fair value estimate for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is $19.15. This implies an estimated downside of 25.7% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 25.7% versus the current market price.

The current financial health read for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is December 1, 2026.

The latest available data indicates no current dividend yield for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F).

The current P/E ratio listed for Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is 55.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Fisher & Paykel Healthcare Corporation Ltd is 14.842 B.

The current enterprise value listed for Fisher & Paykel Healthcare Corporation Ltd is 14.669 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Fisher & Paykel Healthcare Corporation Ltd is OTC-FSPK.F, and the stock is listed on OTC Markets.

Fisher & Paykel Healthcare Corporation Ltd (OTC-FSPK.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Fisher & Paykel Healthcare Corporation Ltd is 0.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Fisher & Paykel Healthcare Corporation Ltd is 99.7%. Free float helps investors understand how much of the share base is available for public trading.